Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 258

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 16
Chunk 258
---
uation assumptions The employee stock-based compensation expense is recognized under ASC 718. Stock-based compensation cost for stock awards is based on the number of shares ultimately expected to vest, estimated at each reporting date based on management’s expectations regarding the relevant performance criteria. The value of the award that is ultimately expected to vest is recognized as expense on a straight-line basis over the employee’s requisite service period for stock awards with a time-based service condition and on a graded vesting basis over the employee’s requisite service period for stock awards with performance and time-based service conditions.Stock-based compensation cost for the employee stock purchase plan is determined at the grant date using the Black-Scholes option pricing model. During the years ended December 31, 2024, 2023 and 2022, the Company did not grant any stock option awards.  The following table displays the assumptions that have been applied to estimate the fair value of the Company’s shares to be issued under the ESPP using the Black-Scholes option pricing model.  

        2024

        2023

        2022

        Expected term (years)

        0.50

        0.50

        0.50

        Risk free interest rate
         
        4.33-5.29%

        3.51-5.36%

        0.07-3.51%

        Expected dividend yield
         
        None

        None

        None

        Volatility
         
        52.85-95.80%

        47.97-71.53%

        47.97-59.21%

       For the year ended December 31, 2024, the Company granted certain RSU awards based on achievement of the market condition total shareholder return (TSR) relative to an objectively selected group of industry peers over a three-year period, with payouts ranging from zero to 120 percent of the target award. The fair value of the TSR component of the awards was $6.94 per share for the 2024 awards determined on the grant date using a Monte Carlo simulation model based on the following assumptions:

        2024

        Expected term (years)

        3.0

        Dividend yield

        —

        Volatility factor

        67.02
        %

        Risk free interest rate

        4.40
        %

 F-33

9. Commitments and contingencies Purchase obligationsThe Company had approximately $58,